AlphaFold predicted structure
GALK1 · P51570

Mean pLDDT
97.2/ 100
Very high
392 residues
Confidence breakdown
- Very high(≥ 90)96%
- Confident(70–90)4%
- Low(50–70)0%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
galactokinase 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Bilateral congenital or childhood onset cataracts
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalNeonatal cholestasis
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
Cholestasis
BIALLELIC, autosomal or pseudoautosomal+2 more panels — install the extension to see the full list inline on any page.
galactokinase deficiency
junctional epidermolysis bullosa with pyloric atresia
Junctional epidermolysis bullosa - pyloric atresia
epidermolysis bullosa, junctional 5A, intermediate
galactosemia
Localized epidermolysis bullosa simplex
junctional epidermolysis bullosa, non-Herlitz type
epidermolysis bullosa simplex 1C, localized
junctional epidermolysis bullosa
Hypercholesterolemia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Galactokinase
Catalyzes the transfer of a phosphate from ATP to alpha-D-galactose and participates in the first committed step in the catabolism of galactose
GALK1 · P51570

Mean pLDDT
97.2/ 100
Very high
392 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0